Q8RF14 AF NFT

Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeick6fcdpkuqspu6vw63xjwvca7gkb2i5bd4v7im326kv2jc4px25q/metadata.json
IPFS of structure file: 
bafybeicombvze4qmeylzzkh4f3546l65ilgp4t2uifqp66gmg5xzbzfytu/AF-Q8RF14-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x12f41c9e42Ae94738EDbf0e38724b13726E509B6
First NFT owner address (bech32): 
genesis1zt6pe8jz46288rkm7r3cwf93xunw2zdksejjch
Current NFT ID #71464 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
71464
Accession (UniProt):
Q8RF14
Name::
Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase
Experimental Method:
Predicted structure
Sequence source:
Fusobacterium nucleatum subsp. nucleatum (strain ATCC 25586 / DSM 15643 / BCRC 10681 / CIP 101130 / JCM 8532 / KCTC 2640 / LMG 13131 / VPI 4355)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q8RF14 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q8RF14|COBT_FUSNN Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase OS=Fusobacterium nucleatum subsp. nucleatum (strain ATCC 25586 / DSM 15643 / BCRC 10681 / CIP 101130 / JCM 8532 / KCTC 2640 / LMG 13131 / VPI 4355) OX=190304 GN=cobT PE=3 SV=1 MKDKNCLFDLINKIESIDNVSIKKAQTELDRKMKPKDSLGVLEDICKKTAGIYGYPLKKLEKKCHIVVAADNGIIEEGVSSCPIEYTSIVSEAMLNQIACIGIFTKTLGIDLNVVDIGMKNDIKRNYPNLIHKKIRRGTNNFYKERAMSINECLEAIFTGIDIINEKSKDYDMFSNGEMGIANTTTSSALLYSVTRQNIDDIVGRGGGLSDEGLNKKKKVIIEACERYNTFEMDAVEMLASVGGFDLACMLGIYVGAALNKKLILVDGFISSVAALLACSLNKNIQDYLLFTHKSEEPGVNIILDYLKEKTFLNMNMRLGEGTGAVLACPIIDCAIEMINTMKSPEEVYNLFNK